Inhibition of CIN85-Mediated Invasion by a Novel SH3 Domain Binding Motif in the Lysyl Oxidase Propeptide

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Sato, Seiichi ^a   Zhao, Yingshe ^b   Imai, Misa ^a   Simister, Philip C ^c   Feller, Stephan M ^c,d   Trackman, Philip C ^e   Kirsch, Kathrin H ^b   Sonenshein, Gail E ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AMAP1 COMPLEX; ANTINEOPLASTIC AGENT; CBL PROTEIN; CELL PROTEIN; LYSYL OXIDASE PROPEPTIDE; PROTEIN CIN85; PROTEIN SH3; UNCLASSIFIED DRUG; CBL PROTEIN, HUMAN; PROTEIN LYSINE 6 OXIDASE; SH3KBP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BREAST CANCER; CANCER CELL CULTURE; CELL INVASION; COMPLEX FORMATION; CONTROLLED STUDY; DELETION MUTANT; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PHENOTYPE; POINT MUTATION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; UBIQUITINATION; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CHEMICAL STRUCTURE; FEMALE; GENETICS; METABOLISM; MOUSE; PATHOLOGY; SRC HOMOLOGY DOMAIN; TUMOR CELL LINE; TUMOR INVASION; XENOGRAFT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID MOTIFS; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HETEROGRAFTS; HUMANS; MICE; MODELS, MOLECULAR; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROTEIN-LYSINE 6-OXIDASE; PROTO-ONCOGENE PROTEINS C-CBL; SRC HOMOLOGY DOMAINS; UBIQUITINATION;

EID: 84885966766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077288     Document Type: Article

References (55)

1. Contente S, Kenyon K, Rimoldi D, Friedman RM, (1990) Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science 249: 796-798.
2. Kaneda A, Wakazono K, Tsukamoto T, Watanabe N, Yagi Y, et al. (2004) Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res 64: 6410-6415.
3. Jeay S, Pianetti S, Kagan HM, Sonenshein GE, (2003) Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. Mol Cell Biol. 23: 2251-2263.
4. Palamakumbura AH, Jeay S, Guo Y, Pischon N, Sommer P, et al. (2004) The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J Biol Chem 279: 40593-40600.
5. Min C, Kirsch KH, Zhao Y, Jeay S, Palamakumbura AH, et al. (2007) The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res 67: 1105-1112.
6. Min C, Yu Z, Kirsch KH, Zhao Y, Vora SR, et al. (2009) A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer Res 69: 6685-6693.
7. Min C, Zhao Y, Romagnoli M, Trackman PC, Sonenshein GE, et al. (2010) Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis. J Cell Biochem 111: 1160-1168.
8. Bais MV, Nugent MA, Stephens DN, Sume SS, Kirsch KH, et al. (2012) Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts. PLoS One 7: e31188.
9. Zhao Y, Min C, Vora SR, Trackman PC, Sonenshein GE, et al. (2009) The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells. J Biol Chem 284: 1385-1393.
10. Take H, Watanabe S, Takeda K, Yu ZX, Iwata N, et al. (2000) Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl. Biochem Biophys Res Commun 268: 321-328.
11. Havrylov S, Redowicz MJ, Buchman VL, (2010) Emerging roles of Ruk/CIN85 in vesicle- mediated transport, adhesion, migration and malignancy. Traffic 11: 721-731.
12. Dikic I, (2002) CIN85/CMS family of adaptor molecules. FEBS Lett 529: 110-115.
13. Gaidos G, Soni S, Oswald DJ, Toselli PA, Kirsch KH, (2007) Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic-complex formation. J Cell Sci 120: 2366-2377.
14. Tibaldi EV, Reinherz EL, (2003) CD2BP3, CIN85 and the structurally related adaptor protein CMS bind to the same CD2 cytoplasmic segment, but elicit divergent functional activities. Int Immunol 15: 313-329.
15. Li SS, (2005) Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 390: 641-653.
16. Mayer BJ, (2001) SH3 domains: complexity in moderation. J Cell Sci 114: 1253-1263.
17. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, et al. (1994) Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76: 933-945.
18. Kowanetz K, Szymkiewicz I, Haglund K, Kowanetz M, Husnjak K, et al. (2003) Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors. J Biol Chem 278: 39735-39746.
19. Nam JM, Onodera Y, Mazaki Y, Miyoshi H, Hashimoto S, et al. (2007) CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. EMBO J 26: 647-656.
20. Zhang J, Zheng X, Yang X, Liao K, (2009) CIN85 associates with endosomal membrances and bins phosphatidic acid. Cell Res. 19: 733-746.
21. Finniss S, Movsisyan A, Billecke C, Schmidt M, Randasso L, et al. (2004) Studying protein isoforms of the adaptor SETA/CIN85/Ruk with monoclonal antibodies. Biochem Biophys Res Commun. 325: 174-182.
22. Treier M, Staszewski LM, Bohmann D, (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain. Cell 78: 787-798.
23. Mayer BJ, Hirai H, Sakai R, (1995) Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr. Biol. 5: 296-305.
24. Vora SR, Guo Y, Stephens DN, Salih E, Vu ED, et al. (2010) Characterization of recombinant lysyl oxidase propeptide. Biochemistry 49: 2962-2972.
25. Eddy SF, Kane SE, Sonenshein GE, (2007) Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Res 67: 9018-9023.
26. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
27. Belguise K, Guo S, Sonenshein GE, (2007) Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res 67: 5763-5770.
28. Sato S, Trackman PC, Maki JM, Myllyharju J, Kirsch KH, et al. (2011) The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells. Mol Cell Biol 31: 2683-2695.
29. Hurtado PA, Vora S, Sume SS, Yang D, St Hilaire C, et al. (2008) Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation. Biochem Biophys Res Commun 366: 156-161.
30. Eswar N, Eramian D, Webb B, Shen MY, Sali A, (2008) Protein structure modeling with MODELLER. Methods Mol Biol 426: 145-159.
31. Emsley P, Lohkamp B, Scott WG, Cowtan K, (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501.
32. Krieger E, Joo K, Lee J, Lee J, Raman S, et al. (2009) Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins 77: 114-122.
33. Sabe H, Hashimoto S, Morishige M, Ogawa E, Hashimoto A, et al. (2009) The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis. Traffic 10: 982-993.
34. Jozic D, Cardenes N, Deribe YL, Moncalian G, Hoeller D, et al. (2005) Cbl promotes clustering of endocytic adaptor proteins. Nat Struct Mol Biol 12: 972-979.
35. Moncalian G, Cardenes N, Deribe YL, Spinola-Amilibia M, Dikic I, et al. (2006) Atypical polyproline recognition by the CMS N-terminal Src homology 3 domain. J Biol Chem 281: 38845-38853.
36. McNiven MA, (2013) Breaking away: matrix remodeling from the leading edge. Trends Cell Biol 23: 16-21.
37. Kirsch KH, Georgescu MM, Shishido T, Langdon WY, Birge RB, et al. (2001) The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction. J Biol Chem 276: 4957-4963.
38. Schmidt MH, Chen B, Randazzo LM, Bogler O, (2003) SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion. J Cell Sci 116: 2845-2855.
39. Shih NY, Li J, Cotran R, Mundel P, Miner JH, et al. (2001) CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol 159: 2303-2308.
40. Kowanetz K, Husnjak K, Holler D, Kowanetz M, Soubeyran P, et al. (2004) CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. Mol Biol Cell 15: 3155-3166.
41. Feng L, Wang JT, Jin H, Qian K, Geng JG, (2011) SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex. Cell Biochem Funct 29: 589-596.
42. Chandra V, Kalia M, Hajela K, Jameel S, (2010) The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex. J Virol 84: 3857-3867.
43. Ceregido MA, Garcia-Pino A, Ortega-Roldan JL, Casares S, López Mayorga O, et al. (2013) Multimeric and differential binding of CIN85/CD2AP with two atypical proline-rich sequences from CD2 and Cbl-b. FEBS J 280(14): 3399-415.
44. Simister PC, Feller SM, (2012) Order and disorder in large multi-site docking proteins of the Gab family-implications for signalling complex formation and inhibitor design strategies. Mol Biosyst 8: 33-46.
45. Roldan JL, Blackledge M, van Nuland NA, Azuaga AI, (2011) Solution structure, dynamics and thermodynamics of the three SH3 domains of CD2AP. J Biomol NMR. 50: 103-117.
46. Maki JM, Rasanen J, Tikkanen H, Sormunen R, Makikallio K, et al. (2002) Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106: 2503-2509.
47. Maki JM, Sormunen R, Lippo S, Kaarteenaho-Wiik R, Soininen R, et al. (2005) Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am J Pathol 167: 927-936.
48. Sommer P, Gleyzal C, Raccurt M, Delbourg M, Serrar M, et al. (1993) Transient expression of lysyl oxidase by liver myofibroblasts in murine schistosomiasis. Lab Invest 69: 460-470.
49. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N, (2000) Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2: 252-257.
50. Maller O, Hansen KC, Lyons TR, Acerbi I, Weaver VM, et al. (2013) Collagen architecture in pregnancy-induced protection from breast cancer. J Cell Sci. (Jul 10. Epub ahead of print).
51. Khalil IA, Kogure K, Futaki S, Harashima H, (2006) High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J Biol Chem 281: 3544-3551.
52. Ren J, Wu X, He W, Shao J, Cheng B, et al. (2011) Lysyl oxidase 473 G>A polymorphism and breast cancer susceptibility in Chinese Han population. DNA Cell Biol 30: 111-116.
53. Wu J, Cai C, Tong D, Hou H, (2012) Lysyl oxidase G473A polymorphism is associated with increased risk of ovarian cancer. Genet Test Mol Biomarkers 16: 915-919.
54. Yoon JH, Park JK, Kang YH, Park YK, Nam SW, et al. (2011) Lysyl oxidase G473A polymorphism is closely associated with susceptibility to gastric cancer in a South Korean population. APMIS 119: 762-768.
55. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA, (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 98(18): 10037-10041.